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iSPOT-DAbnormalities in functional limbic–anterior cingulate–prefrontal circuits associated with emotional reactivity,
evaluation and regulation have been implicated in the pathophysiology of major depressive disorder (MDD).
However, existing knowledge about structural alterations in depression is equivocal and based on cohorts of lim-
ited sample size. This study used voxel-basedmorphometry (VBM) and surface-based cortical thickness to inves-
tigate the structure of these circuits in a large and well-characterized patient cohort with MDD.
Non-geriatric MDD outpatients (n = 102) and age- and gender-matched healthy control participants (n = 34)
provided T1-weighted magnetic resonance imaging data during their baseline visit as part of the International
Study to Predict Optimized Treatment for Depression. Whole-brain VBM volumetric and surface-based cortical
thickness assessments were performed voxel-wise and compared (at p b 0.05 corrected for multiple compari-
sons) between the MDD and control groups.
MDD participants had reduced graymatter volume in the anterior cingulate cortex, regions of the prefrontal cir-
cuits, including dorsolateral and dorsomedial prefrontal cortices, and lateral andmedial orbitofrontal cortices, but
not in limbic regions. Additional reductions were observed cortically in the posterior temporal and parieto-
occipital cortices and, subcortically in the basal ganglia and cerebellum. Focal cortical thinning in the medial
orbitofrontal cortex was also observed for the MDD group. These alterations in volume and cortical thickness
were not associated with severity of depressive symptoms.
The ﬁndings demonstrate that widespread gray matter structural abnormalities are present in a well-powered
study of patients with depression. The patterns of gray matter loss correspond to the same brain functional net-
work regions that were previously established to be abnormal inMDD, whichmay support an underlying struc-
tural abnormality for these circuits.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license. ACC, Anterior Cingulate Cortex;
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Major depressive disorder (MDD) is a leading cause of disability and
has an economic impact in the United States of $42 billion per year
(Mathers and Loncar, 2006). Advances in imaging technology are help-
ing to progress the understanding of the pathophysiology of MDD and
the targeting of new treatments. A substantial body of imaging data
demonstrates spatially distributed functional abnormalities occurring
throughout the brain in MDD (Drevets et al., 2008). The key regions
that have gained consensus for an involvement inMDD include the lim-
bic cortex (amygdala, hippocampus), the cingulate cortex, dorsal stria-
tum and the frontal lobe (dorsolateral prefrontal cortex [DLPFC] and
medial prefrontal cortex [MPFC]). These data have informed prevailing
theories of the mechanisms of MDD, which highlight an imbalance be-
tween anoveractive saliencenetwork (involving in theputamen, amyg-
dala, and anterior cingulate) and decreased responsiveness in regionsse. 
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frontal cortex — DLPFC) (Hamilton et al., 2012). Although much of the
imaging data is derived fromPET and fMRI studies, convergent evidence
from structural studies suggests similar widespread changes can be
seen using structuralmethods. A recent analysis of graymatter structur-
al networks highlighted the presence of global organizational abnor-
malities that are associated with a diagnosis of depression (Singh
et al., in press). In this paper we evaluate the pattern and extent of
gray matter (GM) changes in MDD, and examine whether these pat-
terns of GM loss correspond to the same regions known to be function-
ally abnormal in MDD.
While it is clear that volumetric GM regional loss occurs in
MDD, the precise pattern of this loss has not been clearly deﬁned.
Existing studies in patients with MDD have shown loss of GM vol-
ume across a range of cortical brain regions, including the medial
prefrontal regions of the anterior cingulate cortex and orbitofrontal
cortex (OFC), the lateral prefrontal cortex, the temporal cortex
(Ballmaier et al., 2004), and the pre- and post-central gyri (Taki
et al., 2005). Moderate GM loss has also been observed in subcorti-
cal regions including the putamen and caudate nucleus, as well as
the amygdala and thalamus (Egger et al., 2008; Tang et al., 2007).
Considered overall, the data that supports these changes is limited
due to the small number of participants in most studies, the large
amount of variation in the regions identiﬁed and the enormous
variation in methodology. The heterogeneity between studies is
echoed in two recent meta-analyses which show convergent ﬁnd-
ings for cingulate and OFC regions but differ in their ﬁndings relat-
ing to striatal and limbic structures (Egger et al., 2008; Tang et al.,
2007). Another region which has been consistently identiﬁed in
functional imaging studies of MDD is the DLPFC; however, the
data relating to GM abnormalities in this region are mixed, with
at least 50% of studies failing to report GM changes in this area
(Bora et al., 2012). A further factor that likely contributes to the
variability in the nature of the structural literature relating to
MDD is the heterogeneity of the condition itself.
In this paper, we present a highly powered, single-site study of
structural GM changes in MDD designed to address the gap in the
literature outlined above. We use whole-brain analysis methods,
permitting a systematic evaluation of GM abnormalities occurring
throughout the entire brain. The International Study to Predict Opti-
mized Treatment for Depression (iSPOT-D) is a large trial of treat-
ment prediction in depression (Grieve et al., 2013; Williams et al.,
2011). Our cohort is well characterized and non-geriatric, and the
methods are highly standardized, which is in contrast to much of
the available literature. We have recently presented data from this
study supporting the concept that functional and white matter
Diffusion Tensor Imaging (DTI) structural deﬁcits underlie the
fronto-limbic dysfunction observed in MDD (Grieve et al., 2013;
Korgaonkar et al., 2011, 2012). A large part of the motivation for
this study is to understand the GM changes occurring in MDD in
order to put into these in context of the connectivity abnormalities
that are being seen in both in our work, and by others. The global
patterns of the abnormalities that are being identiﬁed using DTI
and functional MRI suggest that associated GM changes may also
be present which might reﬂect these abnormal networks. We there-
fore hypothesize that the GM volume changes will involve multiple
regions but will be most marked in regions characterized by
hypofunction in functional data or by decreased connectivity in
DTI tractography studies. Speciﬁcally we hypothesize that the sig-
niﬁcant structural changes will occur in the DLPFC — a region char-
acterized by decreased activity in MDD. In addition, based on the
literature and on the strong involvement of the cingulate bundle in
our previous DTI analysis, we hypothesize (i) that the cingulate cortex
and (ii) the OFC—which has a large number of projection ﬁbers
extending from the cingulate region—will both showGMvolume reduc-
tions that reﬂect underlying circuit abnormalities present in MDD.2. Material and methods
2.1. Participants
Magnetic resonance imaging (MRI) data were drawn from the ﬁrst
102 MDD and 34 age- and gender-matched healthy participants who
providedMRI data at Westmead Hospital (SydneyMedical School, Uni-
versity of Sydney) as part of the baseline data collection for the iSPOT-D
study.MDDparticipants in the studywere aged 18–65,ﬂuent in English,
had a total HRSD17 ≥ 16 andmet theDSM-IV criteria for single or recur-
rent nonpsychotic MDD established by MINI Plus and did not have
suicidal tendencies, history of bipolar, schizophrenia, schizoaffective
disorder or psychosis, current primary diagnosis of anorexia, obsessive–
compulsive disorder or primary post traumatic disorder. They did not
have substance dependence, history of brain injury, had suffered loss of
consciousness for greater than ﬁve minutes or any contraindications for
MRI. A complete description of the iSPOT-D study protocol, clinical as-
sessments, inclusion/exclusion criteria and diagnosis procedures of the
overall trial is provided in Williams et al. (2011) and a description of
the imaging sub-study is provided in Grieve et al. (2013). This study
was conducted according to the principles of the Declaration of Helsinki
2008. After the study procedures were fully explained in accordance
with the ethical guidelines of the institutional review board, participants
provided written consent.
Demographic features (e.g., age, gender, years of education) were
gathered at baseline. The 17-item Hamilton Rating Scale for Depression
(HRSD17) was gathered at baseline to measure depressive symptom
severity.
2.2. Image acquisition
Magnetic resonance images were acquired using a 3.0 T GE Signa
HDx scanner (GE Healthcare, Milwaukee, Wisconsin). Acquisition
was performed using an 8-channel head coil. Three-dimensional T1-
weighted magnetic resonance images were acquired in the sagittal
plane using a 3D SPGR sequence (TR = 8.3 ms; TE = 3.2 ms; Flip
Angle = 11°; TI = 500 ms; NEX = 1; ASSET = 1.5; Frequency direc-
tion: S/I). A total of 180 contiguous 1 mm slices were acquired with a
256 × 256 matrix, with an in-plane resolution of 1 mm × 1 mm
resulting in isotropic voxels.
2.3. Voxel-based morphometry analysis
T1 image datawaspre-processed and analyzed using theVBM8 tool-
box (http://dbm.neuro.uni-jena.de/vbm.html) and the SPM8 software
package (http://www.ﬁl.ion.ucl.ac.uk/spm). Images were corrected for
bias-ﬁeld inhomogeneity; tissue-classiﬁed into GM, white matter and
cerebrospinal ﬂuid; and registered to standard space using high-
dimensional DARTEL normalization (Ashburner, 2007). The segmenta-
tion approach is based on an adaptive maximum, a posterior technique
which does not need a priori information about tissue probabilities
(Rajapakse et al., 1997). The segmentation procedure is further reﬁned
by accounting for partial volume effects and by applying a hidden
Markov random ﬁeld model which incorporates spatial prior informa-
tion of the adjacent voxels into the segmentation estimation (Tohka
et al., 2004). The warped tissue type images were modulated to pre-
serve the volume of a particular tissue within a voxel by multiplying
voxel values in the segmented images by the Jacobian determinants
derived from the spatial normalization step. The analysis of these
modulated images allows testing for regional differences in absolute
volume of tissue class. Finally, images were smoothed with a full-
width half-maximum kernel of 8 mm. Statistical analyses were per-
formed on these images for whole-brain comparison of volume be-
tween the MDD and control groups. Regions were labeled with
reference to the Automated Anatomical Labeling (AAL) atlas (Tzourio-
Mazoyer et al., 2002). Brodmann areas (BAs) are also provided to enable
Table 1
Selected demographic features, global and lobar gray matter volumes.
Measures Controls MDD p value
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pose, the publically available atlas distributed with MRIcro was used
(www.mccauslandcenter.sc.edu/mricro/mricro/lesion.html#brod).(n = 34) (n = 102)
Demographic/clinical measures
Age (years) 31.5 ± 12.4 33.8 ± 13.1 0.390
Gender 18 M:16 F 48 M:54 F 0.871
Education (years) 14.7 ± 3.5 14.2 ± 2.9 0.420
Spotcor (IQ measure) 46.8 ± 5.7 46.2 ± 6.6 0.594
HRSD17 baselinea 1.0 ± 1.2 21.0 ± 3.9 b0.0001
Age of onset (years) – 22.1 ± 12.2 –
Disease duration (years) – 11.3 ± 11.8 –
Melancholic subtype – 31% –
Volumetric GM measures
Whole brain (ml)a 885.5 ± 56.9 846.7 ± 79.9 0.010
Frontal lobe (ml)a 237.4 ± 22.0 224.5 ± 23.9 0.007
Temporal lobe (ml)a 144.1 ± 10.6 137.1 ± 12.9 0.005
Parietal lobe (ml)a 126.7 ± 10.1 121.6 ± 13.1 0.038
Occipital lobe (ml)a 97.7 ± 7.2 93.3 ± 9.2 0.014
Cerebellum (ml) 125.4 ± 7.8 120.4 ± 15.3 0.072
Abbreviations: HRSD17, 17-item Hamilton Rating Scale for Depression; MDD, Major De-
pressive Disorder.
a Indicates signiﬁcant difference (p b 0.05).2.4. Cortical thickness and sub-cortical volume analysis
Cortical surface reconstruction and volumetric segmentation was
performed in an automatedmanner using the FreeSurfer image analysis
suite (version 4.3, http://surfer.nmr.mgh.harvard.edu/). The technical
details of these procedures have been previously described elsewhere
(Grieve et al., 2011). Brieﬂy, for each participant, the boundary between
the GM and white matter and the outer surface of the cortex (the pial
surface) was segmented. Cortical thickness measurements at each
point across the cortical mantle were calculated as the closest distance
from the GM/white matter boundary to the GM/cerebrospinal ﬂuid
boundary (Fischl and Dale, 2000). This method uses both intensity
and continuity information from the entire three-dimensionalmagnetic
resonance volume in segmentation and deformation procedures to pro-
duce representations of cortical thickness. The surface representations
are created using spatial intensity gradients across tissue classes
and are therefore not simply reliant on absolute signal intensity. The
surfaces produced are not restricted to the voxel resolution of the orig-
inal data and thus are capable of detecting sub-millimeter differences
between groups. Cortical segmentation and labels were manually
inspected for accuracy. Each participant dataset was then normalized
to an average reference surface template in standard space—provided
with FreeSurfer—to allow for cortical thickness evaluations at every sur-
face point across participants. Registrationwas performed in a spherical
surface-based coordinate system that is adapted to the folding pattern
of each individual dataset, allowing amuch higher localization accuracy
of structural features of the brain across participants (Fischl et al., 1999).
These images were then entered for statistical evaluation of MDD vs.
control groups as described below.2.5. Statistical analyses
Volume and cortical thickness structural differences between the
MDDand healthy participant groupswere evaluated using independent
sample t-tests. Analyses were performed at every voxel for the VBM
data and at every surface point (vertex) for the cortical thickness data.
For the MDD group only, depressive severity was assessed for correla-
tions with both VBM and cortical thickness voxel/vertex-wise. Since
our cohort was age and gender matched we did not co-vary for these
parameters. A statistical threshold of p b 0.05 (false discovery rate
[FDR] corrected for multiple comparisons) was used. Volume and corti-
cal thickness values for the signiﬁcant clusters were extracted using a
5 mm sphere ROI centered on the cluster peak and used to calculate
percent differences between the two groups. For the purposes of giving
a regionally speciﬁc comparator, we also express these local differences
in terms of the volume loss expected in these regions via the normal
aging process in years (i.e., Change in Volume expected in that region
through Normal Aging [CVNA]) using the same ROI. These comparisons
are based on our previously presented data on normal aging in 476 in-
dividuals without a psychiatric or other medical diagnosis (Grieve
et al., 2005, 2011). We use this convention throughout the remainder
of the text.3. Results
3.1. Participant characteristics
Demographic information for the MDD and healthy participant
groups is summarized in Table 1. As expected, the MDD group had
greater depressive severity (HRSD17) compared to healthy participants.3.2. Global and lobar GM volume measurements
The global and lobar GM volumes for MDD vs. controls are summa-
rized in Table 1. Compared to healthy controls, MDD participants had
4.4% less global GM volume than did healthy controls (p b 0.05).
These volumetric differences were greatest in the frontal and temporal
lobes (5.4% and 4.8%, respectively), with signiﬁcant differences also
present in the parietal and occipital lobes. The global GM difference
between depressed participants and controls equated to a CVNA of
14 years. The lobar GM volume differences equated to CVNA values
of 12 years (frontal), 10 years (parietal), 15 years (temporal) and
14 years (occipital). Cerebellar volume differences between the two
groups were not signiﬁcant.
3.3. Whole-brain voxel-level GM volume analysis
The VBM analysis showed large areas of decreased GM volume in
MDD distributed across the brain, with no regions of increased GM vol-
ume. The dominant ﬁndings were of three large bilateral clusters, with
each cluster spanning several contiguous anatomical regions. For conve-
nience, since the three clusterswere bilaterally symmetric, the right and
left components are referred to below as the same cluster number.
These clusters are broadly characterized as follows: (1) the DLPFC (BA
45, 46) with extension inferiorly to the lateral OFC (BA 47) and superi-
orly to involve the pre/post central gyri (Fig. 1, top row), (2) a largemid-
line region spanning the medial orbitofrontal cortex/posterior gyrus
rectus, entire cingulate cortex and the calcarine/lingual gyri (Fig. 1, mid-
dle row), and (3) a broad region in the posterior temporal lobe spanning
the inferior/middle/superior temporal gyri (Fig. 1, bottom row). These
three regions are presented in Table 2, broken down by anatomically
distinct regions classiﬁed using both AAL and Brodmann descriptors.
In addition, several discrete, focal regions of signiﬁcant GM volume re-
duction were present, which are presented by lobe in Table 2. These
dominant ﬁndings are summarized below:
3.3.1. Dorsolateral prefrontal cortex (BA 8, 9, 45, 46), (part of the large
cluster 1)
The DLPFC component encompasses most of BA 45 and the lat-
eral components of BA 46. The GM difference centered at the max-
ima in BA 46 corresponded to a 24% volume difference on the
left (CVNA: 32 years) and a 27% volume difference on the right
(CVNA: 31 years).
Fig. 1. Voxel basedmorphometry volume differences between theMDD and control groups (MDD b controls at p b 0.05 FDR-corrected). The dominant three bilateral clusters are shown
in two axial slices (columns 1 & 2), one coronal slice (column 3) and one sagittal slice (column 4) (the location of the axial and coronal slices is marked on the sagittal slice for reference):
(top row) cluster 1— 1a—dorsolateral prefrontal cortex, 1b— lateral orbitofrontal cortex, 1c—precentral gyrus; (middle row) cluster 2— 2a— gyrus rectus, 1b— anterior cingulate cortex,
1c— posterior cingulate cortex, 1d— precuneus; and (bottom row) cluster 3— 3a— fusiform gyrus, 3b— inferior temporal gyrus, 3c—middle temporal gyrus and 3d— superior temporal
gyrus. Abbreviations: FDR, False Discovery Rate; MDD, Major Depressive Disorder.
335S.M. Grieve et al. / NeuroImage: Clinical 3 (2013) 332–3393.3.2. Medial and lateral orbitofrontal cortices (BA 10, 11, 47), (part of
clusters 1 & 2)
The cluster maxima corresponding to the medial OFC were present
in the middle frontal gyrus (BA 10/11) and the gyrus rectus. The
decreased GM volume in this cluster corresponded to a difference of
approximately 8–10% (CVNA: 23–25 years). The changeswere anatom-
ically symmetric. The gyrus rectus GM differences (26%)were profound
but restricted to the posterior portion (CVNA: N50 years). For the lateral
OFC, the peak clusterwas located in themiddle frontal gyrus (GMdiffer-
ence of 19%, CVNA: 24 years).
3.3.3. Dorsomedial prefrontal cortex (BA 10), (part of cluster 2)
Cluster maxima were found in the bilateral medial frontal gyrus
within the dorsomedial prefrontal cortex (PFC) region. A GM difference
of 11% on the left (CVNA: 37 years) and 11% on the right (CVNA:
N50 years) was found for these clusters.
3.3.4. Anterior cingulate cortex (BA 24, 25, 32), (part of cluster 2)
The anterior cingulate cortex (ACC) component of cluster 2 was
maximal in the caudal ACC (11%) but involved the whole of the ACC
quite homogenously (global ACC ranged from 8 to 11%). The maximal
ACC volume differences were symmetric and corresponded to approxi-
mately CVNA: 26 years.3.3.5. Mid- and posterior cingulate cortices (BA 23, 26), (part of cluster 2)
TheGMvolumedecrease involved the entiremid- and posterior cin-
gulate cortices. The volume differences were quite homogenous and
similar in magnitude to that seen in the ACC, ranging from 8 to 11%
(CVNA: 32–42 years). The changes were anatomically symmetric.
3.3.6. Posterior temporal lobe (BA 18, 19), (part of cluster 3)
Large bilateral regions of decreased GM volume in the MDD group
involve the posterior portions of the temporal lobe. The volume de-
creases in the medial temporal lobe correspond to an average regional
volumetric difference of 10–13% (CVNA: 21–48 years).
3.3.7. Occipital cortex (BA 18, 19)
The GM changes in the occipital regionwere predominantlymidline
(calcarine and lingual sulci) and were contiguous with the medial
PFC and cingulate clusters. Additional occipital lobe clusters were also
present in themiddle occipital gyrus (bilateral) and the right inferior oc-
cipital gyrus. The signiﬁcant regions of volume differences in the occip-
ital lobe were 8–14% (CVNA: 12–38 years).
3.3.8. Other regions
Small focal decreases in GM in the MDD cohort were present in the
left pre- and post-central gyri (continuous with cluster 1). Scattered
Table 2
Summary of signiﬁcant clusters with VBM and cortical thickness differences between controls and MDD participants at p = 0.05 (FDR corrected).
Region MNI space (mm) Cluster size Z score FDR corrected p-value % change
x y z
Cortical thickness differences
Controls b MDD
L — Superior frontal gyrus (BA 11) −21 56 −13 334a 5.13 b0.001 16.4%
L — Lateral orbitofrontal −22 47 −12 334a 4.19 0.002 12.8%
Controls N MDD
L —Medial frontal gyrus (BA 25)/medial orbitofrontal −6 17 −16 8 4.08 0.003 16.1%
Gray matter volume differences
Controls N MDD
Frontal
Dorsolateral prefrontal cortex and lateral OFC
L —Middle frontal gyrus (BA 45/46) −53 32 21 51416b 4.25 0.002 24.1%
R — Inferior frontal gyrus (BA 45/46) 54 38 12 8820a 5.68 b0.001 27.3%
L — Inferior frontal gyrus (BA 44) −47 15 18 51416b 3.37 0.015 9.2%
R —Middle frontal gyrus (BA 47) 48 52 −14 8820a 4.99 b0.001 19.0%
Medial orbitofrontal cortex/posterior gyrus rectus
R — rectal gyrus (BA 11) 4 20 −29 51416b 6.66 b0.001 26.2%
L — Superior/middle frontal gyrus (BA 11) −20 50 −12 51416b 4.45 0.001 8.1%
R — Superior/middle frontal gyrus (BA 10/11) 15 47 −21 51416b 4.13 0.002 9.9%
Dorsomedial prefrontal cortex
L —Medial frontal gyrus (BA 10) −14 56 5 51416b 4.75 b0.001 10.7%
R —Medial frontal gyrus (BA 10) 17 52 13 51416b 4.62 0.001 11.1%
Cingulate cortex
L — Anterior cingulate (BA 32) −21 14 42 51416b 4.89 0.001 10.9%
R — Anterior cingulate (BA 32) 6 45 20 51416b 4.07 0.003 11.4%
R —Mid cingulate (BA 23) 5 −27 45 51416b 4.64 0.001 10.3%
L — Posterior cingulate (BA 23/26) −3 −38 24 51416b 3.57 0.009 7.9%
L — Precuneus/posterior cingulate (BA 7/23) −5 −69 38 51416b 4.58 0.001 11.1%
R — Precuneus/posterior cingulate (BA 7/23) 6 −57 24 51416b 4.04 0.003 10.0%
Other frontal regions
L — Superior frontal gyrus (BA 6)/supplementary motor area −9 11 54 51416b 2.89 0.041 7.0%
R — Precentral gyrus (BA 4) 56 −8 50 8820a 3.69 0.007 20.5%
L — Precentral gyrus (BA 4/6) −60 −7 42 85 3.20 0.021 17.2%
Temporal
L — Fusiform gyrus (BA 37) −45 −60 −21 1681c 4.28 0.002 10.8%
R — Fusiform/inferior temporal gyrus (BA 37) 50 −54 −17 9745d 4.47 0.001 10.3%
R — Inferior temporal gyrus (BA 20) 50 −30 −21 9745d 5.09 b0.001 12.9%
L —Middle temporal gyrus (BA 20) −54 −34 −11 4330e 4.93 b0.001 13.0%
L —Middle temporal gyrus (BA 21/39) −51 −54 6 1375 4.16 0.002 11.6%
R — Superior temporal gyrus (BA 22) 46 −22 0 9745d 4.72 0.001 9.5%
Parietal
L — Postcentral gyrus (BA 2/3) −45 −25 40 261 3.49 0.011 10.3%
R — Postcentral gyrus (BA 2/3) 54 −23 48 8820a 3.79 0.006 13.7%
L — Inferior parietal (BA 40) −39 −48 36 868 3.63 0.008 12.1%
R — Inferior parietal (BA 7) 33 −61 42 41 3.15 0.024 10.9%
Occipital
L — Cuneus/lingual/calcarine gyrus (BA 17/18) −5 −78 26 51416b 5.16 b0.001 14.0%
R — Cuneus/lingual/calcarine gyrus (BA 17/18) 2 −92 −12 51416b 5.28 b0.001 8.1%
L —Middle occipital gyrus (BA 18/19) −32 −82 10 193 3.75 0.006 12.3%
R —Middle occipital gyrus (BA 19) 26 −70 25 606 3.71 0.007 11.6%
R — Inferior occipital gyrus (BA 19) 32 −81 −5 35 3.29 0.017 10.2%
Subcortical
L — Thalamus −8 −4 13 28 3.00 0.032 9.3%
L — Globus pallidus −27 −13 −3 107 3.39 0.014 7.2%
L — Caudate −9 9 8 51416b 2.88 0.042 8.4%
Cerebellum
L — Crus I −57 −57 −32 1681c 4.02 0.003 23.4%
R — Crus I 52 −54 −30 9745d 3.71 0.007 23.4%
R — Lobule VIIb 28 −63 −48 25 2.98 0.034 8.8%
L — Lobule VIIb −28 −63 −45 43 2.97 0.035 8.2%
L —Medial crus I −27 −69 −36 186b 2.94 0.037 7.4%
a, b, c, d and e indicate part of the same cluster.
Abbreviations: BA, Brodmann Area; FDR, False Discovery Rate; L, left; MDD, Major Depressive Disorder; MNI, Montreal Neurological Institute; OFC, Orbitofrontal Cortex; R, right; VBM,
Voxel-Based Morphometry.
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of these were located bilaterally in the posterior crus I region (23%;
CVNA: N50 years). Focal regions of GM volume difference were also
present in the left anterior thalamus, left putamen and left caudate
(GM volume decrease: 9%, 7% and 8%, respectively; CVNA 13–
15 years).3.4. Whole brain cortical thickness analysis
In comparison to the widespread differences in volume, the mea-
sured cortical thickness differences between the MDD and control
groups were limited. The cortical thickness analysis showed a discrete
region of thinned cortex in those with MDD which was centered in
337S.M. Grieve et al. / NeuroImage: Clinical 3 (2013) 332–339the left medial orbitofrontal cortex (16% decrease; p = 0.003). The re-
mainder of the regions identiﬁed in the VBM analysis showed no signif-
icant differences at the whole-brain correction level. Interestingly,
when the contrast MDD N controls was tested, MDD participants were
found to have a focal region of left lateral OFC with increased cortical
thickness compared to controls; however, the cluster size for
this ﬁnding was very small at 8 vertices (16% increase; FDR-corrected
p-value b 0.001).
3.5. Volume and cortical thickness association with depressive severity
In the MDD group, no clusters were found to have signiﬁcant corre-
lations betweendepressive severity (usingHRSD17) andVBMvolumeor
cortical thickness.
4. Discussion
Our data demonstrate conclusively that widespread GM volume ab-
normalities are present in patients with depression. These alterations
are substantial, corresponding to the amount of GM volume loss that,
when averaged over the whole brain, would be expected from nearly
14 years of normal aging. The GM loss is also highly regionally speciﬁc,
with focal regions showing decreases in GMvolumes of nearly twice the
magnitude of the globalmeasure. The distributed and regionally speciﬁc
nature of these alterations provides compelling support for considering
MDDas a condition that involves the impairment of networks across the
brain. Previous studies have used MRI to detect brain structural abnor-
malities in patients with MDD, but they have produced heterogeneous
and often conﬂicting results (Arnone et al., 2012; Bora et al., 2012;
Koolschijn et al., 2009). Ours is the largest study to speciﬁcally examine
GM volumetric changes in MDD and it provides a very robust level of
evidence documenting the structural pattern of GM loss. Our cohort is
well characterized and non-geriatric, with an average age of 34 years
(standard deviation: 13 years). The whole-brain analysis approach
used in the study also means that no a priori regional bias was added
to our ﬁndings.
The magnitude of the GM volume differences found in this study is
striking. This is especially apparent when compared to the volumes of
GM that are lost during the aging process. We have shown that a diag-
nosis ofMDD in a non-geriatric cohort is associatedwith focal decreases
of GM volume that are in excess of that expected from 11 to 50 years of
normal aging, depending on the region. Regional GM differences were
present in the DLPFC (27%), ACC (11%) and the medial orbital frontal
cortex (10%), all regions that have an established role in the pathophys-
iology of MDD. Additional regions of the brain were also found to have
signiﬁcant GM loss with MDD, including the medial temporal lobe
(13%), the gyrus rectus (26%) and the occipital lobe (8–14%).
There is a scarcity of prior data that speciﬁcally examines GM vol-
ume changes in the DLPFC with MDD. Therefore, our demonstration of
a large DLPFC volume reduction represents an important addition to
the literature and is in keeping with the central role of this region in
the dominant models of MDD. The regional changes correlate well
with the abnormal fMRI responses (hypoactivation of the dorsolateral
prefrontal cortex during working memory updating and during con-
scious negative emotion processing) seen in our previous analysis of
fMRI data from this sample (Korgaonkar et al., 2013) and also seen in
other studies (Fitzgerald et al., 2006). While it seems surprising that
such a large effect has not previously been demonstrated, the heteroge-
neity of ﬁndings in this region identiﬁed in meta-analyses suggests that
both methodological and cohort factors may impact on observations of
structural change in this region (Arnone et al., 2012; Bora et al., 2011).
The key methodological factors contributing to this are the variability
in delineating this region across previous studies employing a region
of interest approach and the large inter-individual variability for this re-
gion (Sanches et al., 2009).While a VBM analysis is an unbiasedmethod
to tackle these issues, the necessity for a severe correction for type 1error at the whole brain level may limit statistical power especially
with smaller cohorts. The relatively young age of our cohort is also im-
portant since theDLPFC undergoes acceleratedGM loss during “normal”
aging (Grieve et al., 2005), so in a geriatric MDD cohort these changes
may be attenuated relative to the normal population due to age-
related changes common to both groups. Given the increased preva-
lence of depression that occurs with age (Mirowsky and Ross, 1992),
it is interesting to speculate that age-related GM volume loss in this re-
gion may actually predispose to depression.
The second highest regional GM volume loss occurred in the gyrus
rectus (26% reduction in volume; greater than 50 years CVNA). Previous
data have highlighted the role of this region in emotional regulation and
in depression (Fitzgerald et al., 2008). Substantial GM volume loss was
additionally present in the medial OFC, which is also in agreement
with prior studies (Arnone et al., 2012; Bora et al., 2012; Koolschijn
et al., 2009). GM loss in the medial OFC region was part of a large
paramedian cluster of signiﬁcant GM volume loss that included the pos-
terior gyrus rectus, cingulate cortex and medial occipital lobe. This me-
dial OFC region has been speciﬁcally implicated as a key component in
the circuitry of depression (Drevets et al., 2008). We also observed
that participants with MDD showed a reduction in cortical thickness
in this region. fMRI data supports a distinct role of this region in emo-
tional regulation (Golkar et al., 2012). A longitudinal study demonstrat-
ed a relationship between this cortical structure as an adult and
emotional reactivity measured at 4 months of age, data that implies
the presence of a “hard-wired” structural predisposition to emotional
reactivity (Schwartz et al., 2010). Our ﬁndings of discrete GM volume
and thickness loss in the gyrus rectus replicate previous data
(Ballmaier et al., 2004). Importantly, the medial orbital prefrontal cor-
tex/gyrus rectus is badly affected by magnetic susceptibility artifact in
fMRI studies, and to a lesser extent in DTI studies, due to the sensitivity
of the echo planar imaging sequence to magnetic ﬁeld gradients that
occur adjacent to the paranasal sinuses. These gradients reduce the
contrast-to-noise of the Blood Oxygenation Level-Dependent response
and also cause geometric distortion (Cusack et al., 2005; Grieve,
2000). Due to these effects, global fMRI studies may understate the im-
portance of this region. Perhaps targeted fMRI studies using localized
shims or spin-echo fMRImay be required to fully understand the impor-
tance of this region.
The functional role of the cingulate cortex—and speciﬁcally the
ACC—in depression is well described (Drevets et al., 2008). Our data
shows a largemidline cluster of GMvolume loss,which contiguously in-
volves the cingulate cortex, extending from the medial OFC to the
precuneus and medial occipital cortices. These regions are also the key
components of the default mode network (Greicius et al., 2003). Abnor-
mal resting state functional connectivity of these same regions has been
described in MDD (Greicius et al., 2007). Our previous work using DTI
data showed that connectivity in the cingulate portion of the cingulate
bundle has structural changeswithMDD at baseline and also has an im-
pact on remission (Korgaonkar et al., under review). The OFC has exten-
sive connections with the limbic system, including from the cingulate
cortex (Ongür and Price, 2000). The presence of structural changes in
both the ACC and the OFC supports the notion that MDD may be con-
ceived as primarily a network abnormality.
One of themost striking ﬁndings in our studywas that no signiﬁcant
hippocampal or amygdala GMvolume losswas presentwithMDD. Hip-
pocampal volume loss has been identiﬁed as a signiﬁcant feature of
MDD in one recent meta-analysis of structural brain changes in depres-
sion, but not in a secondmeta-analysis. Neither of these studies demon-
strated amygdala volume loss (Arnone et al., 2012; Bora et al., 2011).
While some of the reasons for this may be methodological such as MR
image acquisition parameters, post acquisition processing and the
method used for volumetric assessment (Geuze et al., 2005; Morey
et al., 2009), it is clear that volumetric changes of the hippocampus
that occur with age, with various neuropsychiatric disorders, and also
in response to stress are quite heterogeneous. Our cohort is a relatively
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11 years. Therefore, our ﬁnding of a lack of changes to the hippocampus
in this groupmay suggest thatGMvolume loss in thehippocampusdoes
not play a key role in non-geriatric depression. Although, we observe
strong abnormal fMRI measures affecting the amygdala in the current
cohort, the associated GM volume changes in the amygdala were
weak (Grieve et al., 2013) and may not be as robust to observe
for assessments made at the whole brain level. Another important ﬁnd-
ing was no signiﬁcant association of depressive severity (using the
HDRS17 scale) with both volume and cortical thickness for the MDD co-
hort. This has not been a consistent ﬁnding in previous studies. While
the lack of correlation in our study replicates previous studies that
found the same (McKinnon et al., 2009; Zou et al., 2010), a signiﬁcant
association between GM volume and depression severity has also
been previously reported (Chen et al., 2007; Cheng et al., 2010).
Our study presents a highly powered, highly standardized cross-
sectional analysis of a well-described cohort with depression, providing
valuable and novel insights into the GM volume changes that character-
ize depression. Given the size of the health and economic impact of this
disorder and the “hit and miss” nature of treatments, there is a clear
need to understand the depressive phenotype in greater detail. Cross-
sectional data is unable to clarify whether these volume changes pre-
cede the development of depression or whether they occur secondary
to the depressive state. Prospective studies with both structural and
functional imaging, correlated with genetics and clinical data in young
cohorts, are needed to provide the data to answer this question.
Our cortical thickness data conﬁrmed the GM changes present in the
medial OFC, but did not detect cortical thinning elsewhere. In contrast to
the GM ﬁndings, we found a very focal region of increased thickness in
the left lateral OFC; however the signiﬁcance of this ﬁnding is unclear.
This ﬁnding may be secondary to the loss in sensitivity implicit in a
whole-brain analysis, or may be a reﬂection that the GM volume
changes are not adequately captured by cortical thickness measures.
Heritability analyses using twins data have demonstrated that there
are different genetic drivers for GM volume and cortical thickness mea-
sures (Winkler et al., 2010). Previous studies (with different MDD
cohorts) that looked at both of these measures have shown mixed
data, with some having shown no cortical thickness changes while
others have shown changes. Further work is clearly needed to under-
stand the morphological nature of the GM volume loss that we have
demonstrated.
In conclusion, we have demonstrated that substantial GM volumet-
ric abnormalities exist in individualswithMDDcompared to individuals
without MDD. These changes are widespread and involve key regions
known to be involved in depression, including the DLPFC, OFC and
ACC. In addition to these “usual suspects”, we identiﬁed a generalized
midline GM volume loss that correlates anatomically with the midline
resting state default mode network regionswhich have been implicated
in depression, as well as strong GM loss in the medial temporal lobe,
cerebellum and pre/post central gyrus. Further work is required to un-
derstand the signiﬁcance of these volumetric changes, including pro-
spective studies and studies that integrate fMRI, DTI and volumetric
data.
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